Viral
Hepatitis
- 0
Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
- 0
FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines
Herpes
- 0
ASM Microbe: What consequences could lifelong Epstein–Barr virus infection have for the brain?
- 0
HR-HPV oral infection rates in England are lower than expected
- 0
A peek behind the paper – Lynn Enquist on the lifecycle of alpha herpesvirus
HIV / AIDS
- 0
IAS 2019: highlights and headlines
- 0
HIV linked to cognitive defects in individuals, despite antiretroviral therapy
- 0
CRISPR and long-acting therapies eliminate HIV DNA from the genome in animal models
HPV
- 0
Could widespread HPV vaccination eliminate cervical cancer?
- 0
Understanding human papillomaviruses using organotypic 3D models – an interview with Sally Roberts
- 0
UK committee recommends HPV vaccinations for adolescent boys
Influenza
- 0
ECCMID19: Some individuals shed flu virus before symptoms appear
- 0
Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines
- 0
Maternal infection: could choline prevent adverse fetal outcomes?
Varicella Zoster
- 0
ECCMID18: Research suggests measles remains a ‘serious threat’ to those under two years old
- 0
Can social media trends predict population vaccinating behavior?
- 0
MMR vaccination: Pro-vaccination strategies fail to debunk popular misconceptions
West Nile
- 0
ECCMID18: Is West Nile virus re-emerging in Greece?
- 0
Malarial drug resistance and congenital complications – the week in infectious diseases
- 0
Could close relatives of the Zika virus also induce birth defects?
